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Abstract
Aim: To construct an HEK293 cell line stably expressing human dopamine D1
receptor (D1R).  Methods: cDNA was amplified by RT-PCR using total RNA
from human embryo brain tissue as the template.  The PCR products were subcloned
into the plasmid pcDNA3 and cloned into the plasmid pcDNA3.1.  The cloned
D1R cDNA was sequenced and stably expressed in HEK293 cells.  Expression of
D1R in HEK293 cells was monitored by the [3H]SCH23390 binding assay.  The
function of D1R was studied by the cAMP accumulation assay, CRE-SEAP re-
porter gene activity assay, and intracellular calcium assay.  Results: An HEK293
cell line stably expressing human D1R was obtained.  A saturation radioligand
binding experiment with [3H]SCH23390 demonstrated that the Kd and Bmax values
were 1.5±0.2 nmol/L and 2.94±0.15 nmol/g of protein, respectively.  In the
[3H]SCH23390 competition assay, D1R agonist SKF38393 displaced
[3H]SCH23390 with an IC50 value of 2.0 (1.5–2.8) µmol/L.  SKF38393 increased
the intracellular cAMP level and CRE-SEAP activity through D1R expressed in
HEK293 cells in a concentration-dependent manner with an EC50 value of 0.25
(0.12–0.53) µmol/L and 0.39 (0.27–0.57) µmol/L at 6 h/0.59 (0.22–1.58) µmol/L
at 12 h, respectively.  SKF38393 also increased the intracellular calcium level in
a concentration-dependent manner with EC50 value of 27 (8.6–70) nmol/L.
Conclusion: An HEK293 cell line stably expressing human D1R was obtained
successfuly.  The study also demonstrated that the CRE-SEAP activity assay could
be substituted for the cAMP accumulation assay for measuring increase in cAMP
levels.  Thus, both intracellular calcium measurements and the CRE-SEAP acti-
vity assay are suitable for high-throughput screening in drug research.
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Introduction
The neurotransmitter dopamine (DA) plays a prominent
role in a variety of vital brain functions including motor
control, short-term memory, attention and reward[1–3].  In the
CNS, DA modulates neuronal excitability by regulating
ligand- and voltage-gated ion channels[4].  The actions of
DA are mediated by a family of seven-transmembrane G
protein-coupled receptors (GPCRs), i.e., D1, D2, D3, D4, and
D5, encoded by five distinct genes[5].  These five subtypes
have been grouped into two different classes based on phar-
macology and biochemistry: the D1-like and D2-like
receptors.  The D1-like receptors, D1 and D5, mediate dopam-
ine stimulation of adenylyl cyclase, whereas D2-like
receptors, D2, D3 and D4, mediate dopamine inhibition of
adenylyl cyclase[5,6].
Assays capable of detecting and quantifying GPCR-ligand
interactions are valuable tools for both fundamental studies
of cell siganaling and drug development.  Drug screening
has mainly relied upon binding assays on membrane prepa-
rations using radioligands or assays measuring second mes-
sengers or enzymes modulated by these receptors.  The abil-
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ity to conduct high-throughput screening based upon func-
tional activity of a given GPCR in a cell-based assay offers a
more direct way of identifying lead agonists or antagonists[7– 9].
In the present study, by using HEK293 cell lines stably
expressing human D1R, we developed a series of method
check character for analyzing GPCR activities in cell lines
including CRE-SEAP activity assay and the intracellular cal-
cium assay.
Materials  and  methods
Materials  High glucose Dulbecco’s modified Eagle’s
medium (DMEM), fetal calf serum, G418, penicillin and
streptomycin were obtained from Gibco.  Restricted enzyme
(HindIII, EcoRI, XhoI, BamHI), T4 DNA ligase, reverse tran-
scriptase and buffer were purchased from Promega (USA).
Pyrobest DNA polymerase and buffer for PCR were obtained
from TaKaRa (Dalian, China).  (±)-SKF-38393 hydrochlo-
ride (SKF38393) and (+)-Butaclamol hydrochloride
(Butaclamol) were obtained from RBI (Natick, MA, USA).
Forskolin, Fluo-3/AM, p-(dipropylsulfamoyl)benzoic acid,
3-isobutyl-1-methyl-2,6(1H,3H)-purine-dione (IBMX),
pluronic F-127, 4-methyl-umbelliferyl phosphate (4-MUP),
HEPES, Triton X-100 , bovine serum albumin leupeptin,
pepstatin A, aprotinin and PMSF were purchased from Sigma
(USA).  [3H]SCH23390 was purchased from Amersham
(USA).  Plasmids pcDNA3, pcDNA3.1(+) and Lipofecta-
mine2000 were purchased from Invitrogen (USA), and pCRE-
SEAP was from BD Biosciences Clontech (USA).  cAMP
assay kit was purchased from Shanghai Second Medical Uni-
versity (Shanghai, China).  Human embryo brain tissue was
donated by Huashan Hospital (Shanghai, China).  PCR prim-
ers were synthesized by Shenyou (Shanghai, China).
Cloning of the human dopamine D1R cDNA  Human
brain total RNA was obtained from human embryo brain
tissue.  The total RNA was reverse-transcribed using oligo-
dT18 as a primer.  With the cDNA, PCR was carried out
using the primers D1R-1SE and D1R-1AS (Table 1).  Gel-
purified PCR product was treated with BamHI/XhoI and
subcloned into the BamHI/XhoI site of the mammalian ex-
pression vector pcDNA3.  With the subcloned D1R-pcDNA3
plasmid as a template, PCR was carried out using the prim-
ers D1R-2SE and D1R-2AS (Table 1), which resulted in full
length codon sequence of cDNA.  Gel-purified PCR prod-
uct was treated with BamHI/EcoRI and cloned into the
BamHI/EcoRI site of the mammalian expression vector
pcDNA3.1(+).
Production of HEK293 cell lines stably expressing
human dopamine D1R  HEK293 Cells were transfected with
the D1R-pcDNA3.1(+) expression vector, using the
Lipofectamine reagent.  Cells were treated with selection
medium containing G418 (1 g/L) for 3 weeks to select sta-
bly transfected cells displaying neomycin resistance.  Be-
tween 2 and 3 weeks into the selection process, resistant cells
began to appear.  They were separated out by serial dilution
and allowed to grow from single cells.  Receptor expression
of single cell-derived colonies was tested by the radioligand
binding assay.
Cell culture  Human embryonic kidney (HEK293) cell
lines were cultured in DMEM containing streptomycin (100
µg/mL), penicillin G (1000 kU/L) and fetal bovine serum
(10%).  Cells were incubated at 37 ºC in 5% CO2.  Stably
transfected HEK293 cell lines were cultured in DMEM high
glucose medium containing streptomycin (100 mg/L), ben-
zylpenicillin (1000 kU/L), G-418 (200 mg/L) and fetal bo-
vine serum (10%).  Cells were incubated at 37 ºC in 5%
CO2.  For passaging, the cells were detached from the cell
culture flask by washing with phosphate-buffered saline
(PBS) and brief incubation with trypsine (0.5 g/L)/EDTA
(0.2 g/L).  The cells were passaged every 3 d.
Membrane preparation  The D1 cells were lifted from
Petri dishes with a cell scraper.  Harvested cells were washed
twice with ice-cold PBS and centrifuged at 420×g for 5 min
at 4 ºC.  The cell pellet was resuspended with hypotonic
buffer (5 mmol/L Tris-Cl, 2 mmol/L EDTA, pH7.4, leupeptin
1 mg/L, pepstatin A 1 mg/L, aprotinin 1 mg/L, PMSF 1 mmol/
L) and sonicated (18 s) three times on ice.  The homogenate
was centrifuged at 960×g for 10 min at 4 ºC.  The precipi-
tated nucleic fraction was discarded and the supernatant was
centrifuged at 40 000×g for 30 min at 4 ºC.  The pellet was
washed with 50 mmol/L Tris-Cl buffer (pH 7.4) and centri-
fuged again with the same conditions.  Finally, the pellet
was resuspended in the same buffer, and protein concentra-
tion was determined by the BCA Kit (Pierce) as described
previously[10].
[3H]SCH23390 binding assay  Membranes (30–50 µg
protein) from D1 cells were resuspended in 50 mmol/L Tris-
Cl (pH 7.4, 120 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L
CaCl2 and 1 mmol/L MgCl2).  Saturation assays were per-
formed at different concentrations of [3H]SCH23390 (0.05–
6 nmol/L), using butaclamol (10 µmol/ L) to obtain nonspe-
cific binding.  Competition curves were obtained by using
0.5 nmol/L [3H]SCH23390 and different concentrations of
dopamine D1R agonist SKF38393.  The incubation was car-
ried out at 37 ºC for 30 min.
Binding assays were stopped by rapid filtration through
Whatman GF/B filters, which were immediately washed three
times with ice-cold buffer.  Filters were then transferred to
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Eppendoff tubes, and scintillation liquid was added to mea-
sure the radioactivity.
cAMP accumulation experiment  After scraping the
cells off the culture plates, they were washed twice with PBS
and resuspended in PBS at a concentration of 0.5×106–
1.0×106 cells/mL.  Aliquots of 0.2 mL were transferred to
test tubes along with the phsophodiesterase inhibitor IBMX
(100 µmol/L) and different concentrations of dopamine D1R
agonist SKF38393 added to a final volume of 0.3 mL.  The
reaction was terminated with 1 mol/L perchloric acid to a
final concentration of 0.5 mol/L after a 15 min incubation at
37 ºC.  Samples were neutralized with 75 µL 2 mol/L KOH,
and the cAMP content in the supernatants were determined
with a protein binding assay[11].  cAMP concentrations were
calculated using a standard curve according to the protocol
of the assay kit.
CRE-SEAP activity assay  Using the secreted form of
human placental alkaline phosphatase (SEAP) as the reporter
enzyme transcriptionally regulated by cAMP response ele-
ments (CREs)[12,15], CRE-SEAP activity was measured.  The
pCRE-SEAP plasmid was transfected into D1 cells using the
calcium phosphate precipitation method (Promega).  Cells
were seeded in 100 m2 plates, and transfection was performed
when cells were 50% confluent.  DNA 25 µg and 60 µL
CaCl2 2 mol/L were mixed in H2O in a total volume of 500
µL and then slowly mixed with HEPES buffered saline
(HBS).  The reaction mixture was incubated at room tem-
perature for 30 min and then evenly added to the cell culture
dish containing 10 mL of fresh media.  After 12 h, the trans-
fection media was replaced with fresh media, and the trans-
fected D1 cells were seeded into 24-well plates (1.5×105 cells
per well) and cultured overnight before experiment[12].  The
medium was then replaced with 500 µL of free serum DMEM
containing 100 µmol/ L IBMX and the different concentra-
tions of SKF38393 then cells were incubated for 6 h and
12 h, respectively.  The SEAP assay was subsequently per-
formed (see below).
Following the incubation period of transiently transfected
cells, the culture medium was inactivated for 30 min at 65 ºC
and centrifuged at 15 000×g at 4 ºC.  The supernatant (80 µL),
was transferred to a new 96-well plate and mixed with 100
µL SEAP assay buffer (50 mmol/L Tris/0.1% BSA buffer,
pH 8.0) containing 36 µmol/L 4-methylumbelliferyl phos-
phate (4-MUP).  The mixture was incubated for 1 h at 37 ºC,
and the fluorescence intensity was measured at 460 nm us-
ing FLUOstar plate reader.  Excitation wavelength was 355 nm.
Intracellular Ca2+ concentration ([Ca2+]i) measure-
ment  Ca2+ fluorescence measurements were performed us-
ing a NOVOstar plate reader with a pipettor system (BMG
Labtechnologies, Offenburg, Germany).  D1 cells were har-
vested with 0.05% trypsin/0.02% EDTA and rinsed with high
glucose DMEM containing 10% fetal bovine serum, 100 mg/
L streptomycin, 1000 U/mL penicillin G.  Pelleted cells were
resuspended in fresh medium and kept under 5% CO2 at 37 ºC
for 1h and vortexed every 15 min.  After twice washes with
Krebs-HEPES buffer, cells were loaded with 5 µmol/ L Fluo-
3/AM containing 1% pluronic F-127 and 2.5 mmol/L
p-(Dipropylsulfamoyl)benzoic acid for 30 min.  Then cells
were rinsed three times with Krebs-HEPES buffer contain-
ing 0.5% bovine serum albumin, diluted, and evenly plated
into 96-well plates at a density of 1×104 cells/well.  Microplates
were kept at 37 ºC for 15 min[13].  Buffer alone or different
concentrations of SKF38393 were then injected sequentially
into separate wells, and fluorescence intensity was measured
at 520 nm for 50 s at 0.2 s intervals.  The excitation wave-
length was 485 nm.
 [Ca2+]i was calculated as follows: [Ca2+]i=Kd (F-Fmin)/
(Fmax-F).  Fmax refers to the fluorescence intensity measured
after permeabilization of the cells with 1% Triton X-100.
Ten mmol/L EDTA was added to chelate Ca2+ and minimum
fluorescence intensity was obtained (Fmin).  A Kd value of
324 nmol/L was used for Fluo-3.
Data analysis  Experiments were performed in triplicate.
All data were expressed as mean±SD and analyzed with the
GraphPad Prism 4.0 program (GraphPad Software, San
Diego, CA, USA).  Student’s t-test was used for statistical
analysis.
Results
Cloning of the human dopamine D1RcDNA  To obtain
the cDNA with full length codon sequence of D1R, a reverse
transcription reaction was carried out using the total RNA
extracted from embryo brain tissue.  Using cDNA with the
full length codon sequence of D1R, a PCR product (1707
bp) was obtained using primers described previously.  The
PCR product was subcloned into pcDNA3 plasmid and a
cDNA (1341 bp) containing the full D1R codon sequence
was obtained using this subcloned vector as a template.  The
cDNA was then cloned into the mammalian expression vector
pcDNA3.1.  Sequence analysis demonstrated that the se-
quence of the constructed D1-pcDNA3.1 expression vector
was identical to that of human D1R cDNA in the gene bank.
Selection of cell clones Colonies of the selected stable
integrants were initially analyzed for human D1R expression
by receptor binding assay using [3H]SCH23390.  From the
transfected HEK293 cell clones, one cell line was obtained
with specific [3H]SCH23390 binding.
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Binding assays with the D1R antagonist [3H]SCH-
23390 Scatchard analysis revealed a Kd value of 1.5±0.2
nmol/L) and Bmax value of 2.95±1.53 nmol/g of protein
(Figure 1).  Figure 2 shows a competition of a D1R agonist
SKF38393 for [3H]SCH23390 with an IC50 value of 2.0 (1.5–
2.8) µmol/L (means, 95% confidence intervals, n=3).
D1R agonist SKF38393 induced accumulation of
cAMP  D1R agonist SKF38393 induced a concentration-
dependent accumulation of cAMP with a EC50 value of 0.25
µmol/L (0.12–0.53) (means, 95% confidence intervals, n=3,
Figure 3).
D1R agonist SKF38393 induced CRE-SEAP activity
In D1 cells transiently transfected with pCRE-SEAP reporter
vector, SKF38393 induced a concentration-dependent in-
crease in the CRE-SAEP activity.  EC50 values at 6 h and
12 h were 0.39 (0.27–0.57) and 0.59 (0.22–1.58) µmol/L
(means, 95% confidence intervals, n=3), respectively.  No
significant difference was found between these two values
(Figure 4).
D1R agonist SKF38393 induced elevated intracellu-
lar calcium level  D1R agonist SKF38393 induced a con-
centration-dependent increase in the intracellular calcium
level.  The EC50 value was 27 (8.5–70) nmol/L (means, 95%
confidence intervals, n=3).  The SKF38393-induced increase
of the intracellular calcium level was completely blocked by
butaclamol (100 µmol/ L), a DA receptor antagonist (Figure 5).
Discussion
In the present study, a HEK293 cell line stably express-
ing human D1R was constructed.  Functional analysis with
cAMP accumulation assay, the CRE-SEAP activity assay,
and intracellular calcium assay demonstrated that their EC50
values were 0.25 (0.12–0.53) µmol/L, 0.39 (0.27–0.57)
µmol/L for 6 h and 0.59 (0.22–1.58) µmol/L for 12 h and 27
(8.6–70) nmol/ L, respectively.  No significant difference in
the EC50 values was found between SKF38393-induced
cAMP accumulation and CRE-SEAP activation.
D1R can activate adenylyl cyclase, which then results in
cAMP production.  At present, radioimmunoassay is one of
the most widely used methods for the measurement of cAMP
accumulation[14].  Cell based assays relying on transcription-
ally controlled reporter gene have been  developed and are
suited to monitoring the cellular responses induced by
Figure 2.  Representative competitive inhibition curve of the dopamine
D1 receptor agonist SKF38393 versus the D1 receptor antagonist
[3H]SCH23390 in membrane preparations from D1 cells.  IC50 values were
expressed as means (95% confidence intervals) obtained from three inde-
pendent experiments performed in triplicate.
Figure 3.  The cAMP accumulation induced by the  D1 receptor agonist
SKF38393 in D1 cells.  The EC50 value was expressed as a mean (95%
confidence intervals) obtained from three independent experiments per-
formed in triplicate.
Figure 1.  Saturation curve of [3H]SCH23390 binding to dopamine D1
receptors in plasma membrane isolated from D1 cells.  Inset: Scatchard
plot of the data and analysis gave the Kd and Bmax values indicated in
RESULTS.  Mean±SD from three independent experiments  performed
in triplicate.
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GPCRs.  Since CRE is a pivotal target in GPCR signaling
pathways, it has become one of the most widely used
response elements in reporter gene assays.  The cAMP re-
sponse element binding protein (CREB), a transcription
factor, is the major regulator of CREs.  It can be activated
(phosphoryl-ated) by protein kinase A (PKA) and members
of calcium/calmodulin kinase (CaMK) family in vitro.  Both
Gαs- and Gαq-coupled receptors are signaled through CREs
[12,15,16].  Since the transcription of CRE-SEAP reporter genes
is controlled by CRE-containing promoters, CRE-SEAP ac-
tivity can be used to monitor the activation of receptors.  In
the present study, the EC50 value obtained using CRE-SEAP
activity assay is similar to that obtained from cAMP accu-
mulation assay.  These results suggest that CRE-SEAP ac-
tivity assay can be used to estimate the Gαs-coupled receptor
function.
Gαs-coupled receptors activate adenylyl cyclase, leading
to an increase in cAMP level.  cAMP activates PKA, which
subsequently phosphorylates different targets.  This pathway
can lead to an increase in intracellular [Ca2+] either from
intracellular Ca2+ stores or from the extracellular matrix[13,17].
Figure 4.  CRE-SEAP activity induced by dopamine D1 receptor agonist
SKF38393.  (A) incubation with SKF38393 for 6 h; (B) incubation with
SKF38393 for 12 h.  EC50 values were expressed as mean (95% confi-
dence intervals) obtained from three independent experiments performed
in triplicate.
Figure 5.  Concentration-response curves for the effect of SKF38393 on
intracellular [Ca2+]i in D1 cells.  n=3.  Mean±SD.  EC50 value was mean
(95% confidence intervals) obtained from three independent experiments
performed in triplicate.
Direct activation of Ca2+ ion channels by Gαs is also possible[13,18].
We found that a significant difference was observed in the
EC50 value of the intracellular calcium assay and cAMP ac-
cumulation assay.  While the EC50 value to induce the cAMP
accumulation was 0.25 (0.12–0.53) µmol/L, the EC50 value
to induce an increase in the intracellular calcium was 27
(8.6–70) nmol/L.  This is likely to reflect the difference in
signaling between intracellular calcium increase and cAMP
accumulation.  Intracellular calcium signals may be directly
transduced, bypassing the adenylyl cyclase pathway and rep-
resenting transient binding with ligand.  Therefore, combi-
nation CRE-SEAP activity assay or a cAMP accumulation
assay with an intracellular calcium assay will obtain more
information on the effect of ligands.  Our study demonstrates
that the CRE-SEAP activity assay and intracellular calcium
assay are suitable for high-throughput screening in drug
research.
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